Health Canada is informing Canadians that Novo Nordisk Canada Inc. is voluntarily recalling one lot (YW60462) of the GlucaGen Hypokit after a quality issue was identified that may affect a small number of kits in the affected lot.
Novo Nordisk Canada Inc. is requesting that wholesalers, pharmacies and hospitals immediately stop sale and recall the affected lot.
In the affected lot, some of the glass vials, which contain the active ingredient glucagon, have been found to be cracked or broken. Use of a cracked vial may result in glucagon fluid leakage and may make the product unusable, which could result in treatment delays if no back-up kit is readily available, and potential health risks.
Affected kits should be returned to a pharmacy for replacement.
Canadians with questions or concerns about these products should speak to a physician or pharmacist, or contact Novo Nordisk Canada
Inc. at 1-800-465-4334. Canadians are also reminded of the importance of visually inspecting their GlucaGen Hypokits before use.
This recall is in addition to the two lots recalled in August due to a separate manufacturing concern (August 25, 2010, Health Canada
communication).
Health Canada has not received any reports of incidents involving this issue.
To report a suspected adverse reaction to these or other health products, please contact Health Canada's Canada Vigilance Program toll-free at 1-866-234-2345, or complete a
Canada Vigilance Reporting Form and send it to us using one of these methods:
Health Canada
613-957-2983
613-957-2991
1-866-225-0709